Abstract:BACKGROUND:Apart from an invasive biopsy, currently no tools are available to confirm the diagnosis of clear cell renal cell carcinoma (ccRCC); this resulted in approximately 30% of patients being diagnosed with metastatic disease.OBJECTIVE:To determine whether urinary microRNAs (miRNAs) can serve as biomarkers to confirm the diagnosis of ccRCC.DESIGN, SETTING, AND PARTICIPANTS:Global miRNA expression was assessed in 28 preoperative urine samples from patients with ccRCC and 18 healthy participants. The independent validation set consisted of 81 ccRCC patients, 24 patients with benign lesions, and 33 healthy participants. We extracted both cell-free and exosomal RNA for miRNA expression analysis using miRNA-specific polymerase chain reaction assays. We also investigated exosomal miRNA secretion in cell line models and performed exosome transfer between RCC and endothelial cell types.OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS:Receiver operating characteristic analysis was applied to identify the discrimination power of miRNAs.RESULTS AND LIMITATIONS:Overall, miR-126-3p combined with miR-449a or with miR-34b-5p could significantly distinguish ccRCC patients from healthy participants (miR-126-3p-miR-449a: area under the curve [AUC]: 0.84; 95% confidence interval [CI], 0.7620-0.9151; p<0.001; miR-126-3p-miR-34b-5p: AUC: 0.79; 95% CI, 0.7013-0.8815; p<0.001). The combination of miR-126-3p and miR-34b-5p was also able to distinguish small renal masses (pT1a, ≤4cm) from healthy controls (AUC: 0.79; 95% CI, 0.6848-0.8980; p<0.001). Using miR-126-3p and miR-486-5p in combination, we were able to differentiate between benign lesions and ccRCC (AUC: 0.85; 95% CI, 0.7295-0.9615; p<0.01). The expression of a number of miRNAs returned to a level comparable with health after surgery. Kidney cancer cell lines were found to secrete exosomal miR-126-3p, miR-17-5p, miR-21-3p, and miR-25-3p, and these miRNAs were found to be internalized by other cell types.CONCLUSIONS:We identified exosomal miRNAs as potential noninvasive diagnostic urinary biomarkers for ccRCC and provided evidence that miRNAs are secreted by the tumor and can function as a tool for intercellular communication.PATIENT SUMMARY:We identified urinary microRNAs that can serve as diagnostic biomarkers for clear cell renal cell carcinoma.

Exosomes in the Diagnosis and Treatment of Renal Cell Cancer

Exosomes in renal cell carcinoma: challenges and opportunities

Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles

Extracellular Vesicles in Renal Cell Carcinoma: Multifaceted Roles and Potential Applications Identified by Experimental and Computational Methods

Advances in the Research of Exosomes in Renal Cell Carcinoma: from Mechanisms to Applications

Exosome: Emerging Biomarker in Breast Cancer

Diagnostic, prognostic, and therapeutic potential of exosomal microRNAs in renal cancer

Exosome in renal cell carcinoma progression and implications for targeted therapy

Current status of research on exosomes in general, and for the diagnosis and treatment of kidney cancer in particular

Exosomes as renal inductive signals in health and disease, and their application as diagnostic markers and therapeutic agents

Exosomes: Emerging Therapy Delivery Tools and Biomarkers for Kidney Diseases

Exosome Mediated Multidrug Resistance in Cancer.

Exosomes: Diagnostic Biomarkers and Therapeutic Delivery Vehicles for Cancer.

Extracellular vesicles in diagnosis and therapy of kidney diseases

Exosomes: a promising avenue for cancer diagnosis beyond treatment

Exosomes: from basic research to clinical diagnostic and therapeutic applications in cancer

Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer

Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma.

Exosomes in diagnostic and therapeutic applications of ovarian cancer

Exosomes: Key Players for Treatment of Cancer and Their Future Perspectives

Exosomes in Cancer: Diagnostic and Therapeutic Applications